Health effects of long-term rapamycin treatment: The impact on mouse health of enteric rapamycin treatment from four months of age throughout life

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Fischer, Kathleen E ^a,b   Gelfond, Jonathan A L ^a   Soto, Vanessa Y ^a   Han, Chul ^c   Someya, Shinichi ^c   Richardson, Arlan ^a,b,e   Austad, Steven N ^a,b,d  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b University of Texas Health Science Center   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN;

AGE; ANIMAL EXPERIMENT; ARTICLE; BODY COMPOSITION; BODY MASS; CHRONIC DRUG ADMINISTRATION; COCHLEA; CONTROLLED STUDY; DRUG BLOOD LEVEL; FAT MASS; FEMALE; GAIT; GRIP STRENGTH; HEALTH STATUS; INFANT; LIFE EXPECTANCY; LIFESPAN; LONG TERM CARE; LONGITUDINAL STUDY; MALE; METABOLIC RATE; MORBIDITY; MOUSE; NONHUMAN; PHENOTYPE; ROTAROD TEST; SEX DIFFERENCE; SURVIVAL TIME; AGING; ANIMAL; C57BL MOUSE; DRUG EFFECTS; LONGEVITY; SLEEP;

ANIMALIA; MUS;

AGING; ANIMALS; FEMALE; LONGEVITY; MALE; MICE; MICE, INBRED C57BL; SEX FACTORS; SIROLIMUS; SLEEP;

EID: 84929340201     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126644     Document Type: Article

References (46)

1. Flynn JM, O'Leary MN, Zambataro CA, Academia EC, Presley MP, Garrett BJ, et al. Late-life rapamycin treatment reverses age-related heart dysfunction. Aging Cell. 2013; 12(5):851-62. doi: 10.1111/acel. 12109 PMID: 23734717.
2. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009; 460(7253):392-5. doi: 10.1038/ nature08221 PMID: 19587680
3. Miller RA, Harrison DE, Astle CM, Baur JA, Boyd AR, de CR, et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. JGerontolA BiolSciMedSci. 2011; 66 (2):191-201. doi: glq178 [pii];doi: 10.1093/gerona/glq178
4. Anisimov VN, Zabezhinski MA, Popovich IG, Piskunova TS, Semenchenko AV, Tyndyk ML, et al. Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. Cell Cycle. 2011; 10(24):4230-6. doi: 18486 [pii];doi: 10.4161/cc.10.24.18486 PMID: 22107964
5. Chen C, Liu Y, Liu Y, Zheng P. mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. SciSignal. 2009; 2(98):ra75.
6. Medvedik O, Lamming DW, Kim KD, Sinclair DA. MSN2 and MSN4 link calorie restriction and TOR to sirtuin-mediated lifespan extension in Saccharomyces cerevisiae. PLoS Biol. 2007; 5(10):e261. doi: 06-PLBI-RA-0346 [pii];doi: 10.1371/journal.pbio.0050261 PMID: 17914901
7. Powers RW III, Kaeberlein M, Caldwell SD, Kennedy BK, Fields S. Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev. 2006; 20(2):174-84. PMID: 16418483
8. Kapahi P, Chen D, Rogers AN, Katewa SD, Li PW, Thomas EL, et al. With TOR, less is more: a key role for the conserved nutrient-sensing TOR pathway in aging. Cell Metab. 2010; 11(6):453-65. doi: S1550-4131(10)00153-1 [pii];doi: 10.1016/j.cmet.2010.05.001 PMID: 20519118
9. Kaeberlein M, Powers RW III, Steffen KK, Westman EA, Hu D, Dang N, et al. Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science. 2005; 310(5751):1193-6. PMID: 16293764
10. Katewa SD, Kapahi P. Role of TOR signaling in aging and related biological processes in Drosophila melanogaster. Experimental gerontology. 2011; 46(5):382-90. Epub 2010/12/07. doi: 10.1016/j.exger. 2010.11.036 PMID: 21130151; PubMed Central PMCID: PMCPmc3058120.
11. Zhang Y, Bokov A, Gelfond J, Soto V, Ikeno Y, Hubbard G, et al. Rapamycin extends life and health in C57BL/6 mice. The journals of gerontology Series A, Biological sciences and medical sciences. 2014; 69(2):119-30. doi: 10.1093/gerona/glt056 PMID: 23682161; PubMed Central PMCID: PMC4038246.
12. Wullschleger S, Loewith R, Hall MN. TOR signaling in growth and metabolism. Cell. 2006; 124(3):471-84. doi: S0092-8674(06)00108-5 [pii];doi: 10.1016/j.cell.2006.01.016 PMID: 16469695
13. Caccamo A, Majumder S, Richardson A, Strong R, Oddo S. Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. JBiolChem. 2010; 285(17):13107-20. doi: M110.100420 [pii];doi: 10.1074/jbc.M110.100420 PMID: 20178983
14. Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O, Bredesen D, et al. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoSOne. 2010; 5(4):e9979. doi: 10.1371/journal.pone.0009979 PMID: 20376313
15. Wilkinson JE, Burmeister L, Brooks SV, Chan CC, Friedline S, Harrison DE, et al. Rapamycin slows aging in mice. Aging Cell. 2012; 11(4):675-82. doi: 10.1111/j.1474-9726.2012.00832.x PMID: 22587563
16. Komarova EA, Antoch MP, Novototskaya LR, Chernova OB, Paszkiewicz G, Leontieva OV, et al. Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/- mice. Aging. 2012; 4 (10):709-14. Epub 2012/11/06. PMID: 23123616; PubMed Central PMCID: PMCPmc3517941.
17. Livi CB, Hardman RL, Christy BA, Dodds SG, Jones D, Williams C, et al. Rapamycin extends life span of Rb1+/- mice by inhibiting neuroendocrine tumors. Aging. 2013; 5(2):100-10. PMID: 23454836; PubMed Central PMCID: PMC3616197.
18. Pakala R, Stabile E, Jang GJ, Clavijo L, Waksman R. Rapamycin attenuates atherosclerotic plaque progression in apolipoprotein E knockout mice: inhibitory effect on monocyte chemotaxis. J CardiovascPharmacol. 2005; 46(4):481-6. PMID: 16160601
19. Majumder S, Caccamo A, Medina DX, Benavides AD, Javors MA, Kraig E, et al. Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1beta and enhancing NMDA signaling. Aging Cell. 2011. doi: 10.1111/j.1474-9726.2011.00791.x
20. Halloran J, Hussong SA, Burbank R, Podlutskaya N, Fischer KE, Sloane LB, et al. Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice. Neuroscience. 2012; 223C:102-13. doi: S0306-4522(12)00672-0 [pii];doi: 10.1016/j.neuroscience.2012.06.054
21. Neff F, Flores-Dominguez D, Ryan DP, Horsch M, Schroder S, Adler T, et al. Rapamycin extends murine lifespan but has limited effects on aging. The Journal of clinical investigation. 2013; 123(8):3272-91. Epub 2013/07/19. doi: 10.1172/jci67674 PMID: 23863708; PubMed Central PMCID: PMCPmc3726163.
22. Fang Y, Westbrook R, Hill C, Boparai RK, Arum O, Spong A, et al. Duration of rapamycin treatment has differential effects on metabolism in mice. Cell Metab. 2013; 17(3):456-62. doi: 10.1016/j.cmet.2013. 02.008 PMID: 23473038; PubMed Central PMCID: PMC3658445.
23. Spong A, Bartke A. Rapamycin slows aging in mice. Cell Cycle. 2012; 11(5):845. Epub 2012/02/24. doi: 10.4161/cc.11.5.19607 PMID: 22356747.
24. Lamming DW, Ye L, Katajisto P, Goncalves MD, Saitoh M, Stevens DM, et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science. 2012; 335 (6076):1638-43. doi: 335/6076/1638 [pii];doi: 10.1126/science.1215135 PMID: 22461615
25. Lamming DW, Ye L, Astle CM, Baur JA, Sabatini DM, Harrison DE. Young and old genetically heterogeneous HET3 mice on a rapamycin diet are glucose intolerant but insulin sensitive. Aging Cell. 2013; 12(4):712-8. doi: 10.1111/acel.12097 PMID: 23648089; PubMed Central PMCID: PMC3727050.
26. Smith JM, Nemeth TL, McDonald RA. Current immunosuppressive agents: efficacy, side effects, and utilization. PediatrClinNorth Am. 2003; 50(6):1283-300. PMID: 14710781
27. Welzl K, Kern G, Mayer G, Weinberger B, Saemann MD, Sturm G, et al. Effect of different immunosuppressive drugs on immune cells from young and old healthy persons. Gerontology. 2014; 60(3):229-38. Epub 2014/01/18. doi: 10.1159/000356020 PMID: 24434865.
28. Hinojosa CA, Mgbemena V, Van RS, Austad SN, Miller RA, Bose S, et al. Enteric-delivered rapamycin enhances resistance of aged mice to pneumococcal pneumonia through reduced cellular senescence. ExpGerontol. 2012; 47(12):958-65. doi: S0531-5565(12)00250-1 [pii];doi: 10.1016/j.exger.2012.08. 013 PMID: 22981852
29. Turner AP, Shaffer VO, Araki K, Martens C, Turner PL, Gangappa S, et al. Sirolimus enhances the magnitude and quality of viral-specific CD8+ T-cell responses to vaccinia virus vaccination in rhesus macaques. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2011; 11(3):613-8. Epub 2011/02/24. doi: 10. 1111/j.1600-6143.2010.03407.x PMID: 21342450; PubMed Central PMCID: PMCPmc3076606.
30. Dickinson JM, Fry CS, Drummond MJ, Gundermann DM, Walker DK, Glynn EL, et al. Mammalian target of rapamycin complex 1 activation is required for the stimulation of human skeletal muscle protein synthesis by essential amino acids. JNutr. 2011; 141(5):856-62. doi: jn.111.139485 [pii];doi: 10.3945/ jn.111.139485 PMID: 21430254
31. Aoyagi T, Kusakari Y, Xiao CY, Inouye BT, Takahashi M, Scherrer-Crosbie M, et al. Cardiac mTOR protects the heart against ischemia-reperfusion injury. AmJPhysiol Heart CircPhysiol. 2012; 303(1):H75-H85. doi: ajpheart.00241.2012 [pii];doi: 10.1152/ajpheart.00241.2012 PMID: 22561297
32. Stoica L, Zhu PJ, Huang W, Zhou H, Kozma SC, Costa-Mattioli M. Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage. ProcNatlAcadSciUSA. 2011; 108(9):3791-6. doi: 1014715108 [pii];doi: 10.1073/pnas. 1014715108 PMID: 21307309
33. Parsons RG, Gafford GM, Helmstetter FJ. Translational control via the mammalian target of rapamycin pathway is critical for the formation and stability of long-term fear memory in amygdala neurons. JNeurosci. 2006; 26(50):12977-83. doi: 26/50/12977 [pii];doi: 10.1523/JNEUROSCI.4209-06.2006 PMID: 17167087
34. Larsen JL, Bennett RG, Burkman T, Ramirez AL, Yamamoto S, Gulizia J, et al. Tacrolimus and sirolimus cause insulin resistance in normal sprague dawley rats. Transplantation. 2006; 82(4):466-70. doi: 10.1097/01.tp.0000229384.22217.15;00007890-200608270-00005 [pii]. PMID: 16926589
35. Fok WC, Chen Y, Bokov A, Zhang Y, Salmon AB, Diaz V, et al. Mice fed rapamycin have an increase in lifespan associated with major changes in the liver transcriptome. PLoS One. 2014; 9(1):e83988. Epub 2014/01/11. doi: 10.1371/journal.pone.0083988 PMID: 24409289; PubMed Central PMCID: PMCPmc3883653.
36. Ikeno Y, Hubbard GB, Lee S, Richardson A, Strong R, Diaz V, et al. Housing density does not influence the longevity effect of calorie restriction. JGerontolA BiolSciMedSci. 2005; 60(12):1510-7. PMID: 16424282
37. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. The journals of gerontology Series A, Biological sciences and medical sciences. 2001; 56(3):M146-56. Epub 2001/03/17. PMID: 11253156.
38. Someya S, Yu W, Hallows WC, Xu J, Vann JM, Leeuwenburgh C, et al. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell. 2010; 143 (5):802-12. Epub 2010/11/26. doi: 10.1016/j.cell.2010.10.002 PMID: 21094524; PubMed Central PMCID: PMCPmc3018849.
39. Kaeberlein M, Kennedy BK. Ageing: A midlife longevity drug? Nature. 2009; 460(7253):331-2. Epub 2009/07/17. doi: 10.1038/460331a PMID: 19606132.
40. Someya S, Xu J, Kondo K, Ding D, Salvi RJ, Yamasoba T, et al. Age-related hearing loss in C57BL/6J mice is mediated by Bak-dependent mitochondrial apoptosis. Proc Natl Acad Sci U S A. 2009; 106 (46):19432-7. Epub 2009/11/11. doi: 10.1073/pnas.0908786106 PMID: 19901338; PubMed Central PMCID: PMCPmc2780799.
41. Pack AI, Galante RJ, Maislin G, Cater J, Metaxas D, Lu S, et al. Novel method for high-throughput phenotyping of sleep in mice. Physiol Genomics. 2007; 28(2):232-8. doi: 00139.2006 [pii];doi: 10.1152/ physiolgenomics.00139.2006 PMID: 16985007
42. Judge JO, Davis RB III, Ounpuu S. Step length reductions in advanced age: the role of ankle and hip kinetics. JGerontolA BiolSciMedSci. 1996; 51(6):M303-M12. PMID: 8914503
43. McFadyen MP, Kusek G, Bolivar VJ, Flaherty L. Differences among eight inbred strains of mice in motor ability and motor learning on a rotorod. Genes Brain Behav. 2003; 2(4):214-9. PMID: 12953787
44. Schellinck HMC DP, Brown RE. How many ways can mouse behavioral experiments go wrong? Confounding variables in mouse models of neurodegenerative diseases and how to control them. In: Brockman HJ, editor. Advances in the Study of Behavior. Burlington, VT: Academic Press; 2010. p. 255- 366.
45. Miller RA, Harrison DE, Astle CM, Fernandez E, Flurkey K, Han M, et al. Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction. Aging Cell. 2014; 13(3):468-77. Epub 2013/12/18. doi: 10.1111/acel.12194 PMID: 24341993; PubMed Central PMCID: PMCPmc4032600.
46. Aigouy B, Mirouse V. ScientiFig: a tool to build publication-ready scientific figures. Nature methods. 2013; 10(11):1048. doi: 10.1038/nmeth.2692 PMID: 24173380.